We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Self-Assembling Nanoparticles Could Optimize MRI Scanning for Diagnosis of Cancer

By MedImaging International staff writers
Posted on 06 Aug 2014
Print article
Image: A nanoparticle developed by researchers at Imperial College London could boost the effectiveness of MRI scanning by zeroing in on receptors found in cancerous cells (Photo courtesy of Imperial College London).
Image: A nanoparticle developed by researchers at Imperial College London could boost the effectiveness of MRI scanning by zeroing in on receptors found in cancerous cells (Photo courtesy of Imperial College London).
To help clinicians diagnose cancer earlier, scientists have designed a new self-assembling nanoparticle that targets tumors.

The new nanoparticle, developed by researchers from Imperial College London (UK), enhances the effectiveness of magnetic resonance imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells.

The nanoparticle is coated with a specialized protein, which searches for specific signals given off by tumors, and when it finds a tumor, it begins to interact with the cancerous cells. This interaction shreds off the protein coating, causing the nanoparticle to self-assemble into a much larger particle so that it is more visible on the scan.

The new study published July 2014 in the journal Angewandte Chemie, used cancer cells and mouse models to compare the effects of the self-assembling nanoparticle in MRI scanning against commonly used imaging agents and found that the nanoparticle produced a more powerful signal and created a clearer MRI image of the tumor. The scientists noted that the nanoparticle increases the sensitivity of MRI scanning and will ultimately enhance the physician’s ability to detect cancerous cells at much earlier stages of development.

Prof. Nicholas Long, from the department of chemistry at Imperial College London, reported that the findings show real potential for improving cancer diagnosis. “By improving the sensitivity of an MRI examination, our aim is to help doctors spot something that might be cancerous much more quickly. This would enable patients to receive effective treatment sooner, which would hopefully improve survival rates from cancer. MRI scanners are found in nearly every hospital up and down the country and they are vital machines used every day to scan patients’ bodies and get to the bottom of what might be wrong. But we are aware that some doctors feel that even though MRI scanners are effective at spotting large tumors, they are perhaps not as good at detecting smaller tumors in the early stages.”

The newly designed nanoparticle provides a tool to improve the sensitivity of MRI scanning, and the scientists are now working to enhance its effectiveness. Prof. Long said, “We would like to improve the design to make it even easier for doctors to spot a tumor and for surgeons to then operate on it. We’re now trying to add an extra optical signal so that the nanoparticle would light up with a luminescent probe once it had found its target, so combined with the better MRI signal it will make it even easier to identify tumors.”

Before evaluating and injecting the nontoxic nanoparticle into mice, the scientists had to make certain that it would not become so large when it self-assembled that it would cause damage. They injected the nanoparticle into a saline solution inside a lab petri dish and tracked its growth over a four-hour period. The nanoparticle grew from 100-800 nm—still small enough to not cause any harm.

The scientists are now improving the nanoparticle and hope to assess their design in a human trial within the next three to five years.

Dr. Juan Gallo, from the department of surgery and cancer at Imperial College London, said, “We’re now looking at fine tuning the size of the final nanoparticle so that it is even smaller but still gives an enhanced MRI image. If it is too small the body will just secrete it out before imaging, but too big and it could be harmful to the body. Getting it just right is really important before moving to a human trial.”

Related Links:

Imperial College London


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
C-Arm with FPD
Digiscan V20 / V30
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.